IL-6R distribution in normal human and cynomolgus monkey tissues

Regulatory Toxicology and Pharmacology

Volumn 53, Issue 1, 2009, Pages 46-51

  Kato, Atsuhiko ^a   Watanabe, Takeshi ^a   Yamazaki, Masaki ^a   Deki, Toshiaki ^a   Suzuki, Masami ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

IL 6R; Immunohistochemistry; Normal human and monkey tissues; Tissue cross reactivity study; Tocilizumab

Indexed keywords

ATLIZUMAB; GLYCOPROTEIN GP 130; INTERLEUKIN 6 RECEPTOR; PEROXIDASE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CROHN DISEASE; CYTOKINE RELEASE; DIGESTIVE SYSTEM; ENDOCRINE GLAND; EPIDERMIS; EXOCRINE GLAND; GENITAL SYSTEM; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; LYMPHOID TISSUE; MONKEY; MULTIPLE MYELOMA; MUSCLE TISSUE; NERVOUS TISSUE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DENSITY; RESPIRATORY EPITHELIUM; RHEUMATOID ARTHRITIS; SPECIES DIFFERENCE; STAINING; TISSUE DISTRIBUTION; URINARY TRACT;

3,3'-DIAMINOBENZIDINE; ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; MACACA FASCICULARIS; MALE; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

MACACA FASCICULARIS;

EID: 58749105621     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.10.007     Document Type: Article

References (14)

1. Imazeki I., Saito H., Hasegawa M., Shinkura H., Kishimoto T., and Ohsugi Y. IL-6 functions in cynomolgus monkeys blocked by a humanized antibody to human IL-6 receptor. Int. J. Immunopharmacol. 20 (1998) 345-357
2. Kallen K.J. The role of transsignalling via the agonistic soluble IL-6 receptor in human disease. Biochem. Biophys. Acta 1592 (2002) 323-343
3. Kato A., Matsuo S., Takaia H., Uchiyama Y., Mihara M., and Suzuki M. Early effects of tocilizumab on bone and bone marrow lesions in a collagen-induced arthritis monkey model. Exp. Mol. Pathol. 84 (2008) 262-270
4. Mihara M., Kotoh M., Nishimoto N., Oda Y., Kumagai E., Takagi N., Tsunemi K., Ohsugi Y., Kishimoto T., Yoshizaki K., and Takeda Y. Humanized antibody to human interleukin-6 receptor inhibits the development of collagen arthritis in cynomolgus monkeys. Clin. Immunol. 98 (2001) 319-326
5. Mihara M., Nishimoto N., and Ohsugi Y. The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody. Expert Opin. Biol. Ther. 5 (2005) 683-690
6. Mihara M., Kasutani K., Okazaki M., Nakamura A., Kawai S., Sugimoto M., Matsumoto Y., and Ohsugi Y. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Int. Immunopharmacol. 5 (2005) 1731-1740
7. Naka T., Nishimoto N., and Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 4 (2002) S233-S242
8. Nishimoto N., and Kishimoto T. Inhibition of IL-6 for the treatment of inflammatory diseases. Curr. Opin. Pharmacol. 4 (2004) 386-391
9. Ohsugi Y. Recent advances in immunopathophysiology of interleukin-6: An innovative therapeutic drug, tocilzumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. Biol. Pharm. Bull. 30 (2007) 2001-2006
10. Paul-Pletzer K. Tocilizumab: blockade of interleukin-6 signaling pathway as a therapeutic strategy for inflammatory disorders. Drugs Today 42 (2006) 559-576
11. Sato K., Tsuchiya M., Saldanha J., Koishihara Y., Ohsugi Y., Kishimoto T., and Bendig M.M. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res. 53 (1993) 851-856
12. Shinkura H., Imazeki I., Yamazaki M., Oda Y., Kotoh M., and Mihara M. In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 functions in primates. Anticancer Res. 18 (1998) 1217-1222
13. Stein B., and Sutherlan M.S.K. IL-6 as a drug discovery target. Drug Discov. Today 3 (1998) 202-213
14. Taga T., Kawanishi Y., Hardy R.R., Hirano T., and Kishimoto T. Receptors for B cell stimulatory factor 2, quantitation, specificity, distribution, and regulation of their expression. J. Exp. Med. 166 (1987) 967-981